An update from Evoke Pharma (EVOK) is now available.
Evoke Pharma, Inc. has announced the appointment of Matthew J. D’Onofrio as the new CEO, effective March 31, 2024. D’Onofrio, a co-founder of the company, takes over from the outgoing CEO, Dave A. Gonyer, who resigned for personal reasons without any disputes concerning company operations. Alongside his new role, D’Onofrio will serve on the company’s board, bringing his extensive experience since 2007 to lead Evoke Pharma into its next chapter.
See more insights into EVOK stock on TipRanks’ Stock Analysis page.
